Pemvidutide
3 research papers indexed
Harrison 2025 - Pemvidutide in MASLD: Randomized Phase 2 Trial
140
Journal of Hepatology
·2025RCTHumanMetabolic dysfunction-associated steatotic liver disease / liver fat reductionSourceRCT
Nestor 2022 - ALT-801 GLP-1/Glucagon Dual Agonist in NASH Models
53
Communications Biology
·2022PreclinicalAnimalNASH / metabolic dysfunction-associated liver diseaseSourcePreclinical
Noureddin 2025 — Pemvidutide Phase 2 MASH Trial
16
The Lancet
·2025RCTHumanMASH with liver fibrosisSourceRCT